Brain Tumor Diagnosis And Therapeutics Market Size, Share & Trends Report

Brain Tumor Diagnosis And Therapeutics Market Size, Share & Trends Analysis Report By Type (MRI, CT Scan, Tissue Sampling, PET-CT Scan, Cerebral Arteriogram, Lumbar Puncture, Molecular Testing, And EEG), By Region, And Segment Forecasts, 2018 - 2025

  • Published Date: Jan, 2017
  • Base Year for Estimate: 2015
  • Report ID: GVR-1-68038-349-2
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2015
  • Number of Pages: 100

Table of Contents

Chapter 1. Methodology and Scope
                     1.1. Research Methodology
                     1.2. Research Scope & Assumptions
                     1.3. List of Data Sources
Chapter 2. Executive Summary
                     2.1. Market Snapshot
Chapter 3. Brain Tumor Diagnosis and Therapeutics Market Variables, Trends & Scope
                     3.1. Market Segmentation & Scope
                     3.2. Market Driver Analysis
                     3.3. Penetration & Growth Prospect Mapping
                     3.4. SWOT Analysis, by Factor
                           3.4.1. Political
                           3.4.2. Economic
                           3.4.3. Technological
                     3.5. Industry Analysis - Porter’s
Chapter 4. Brain Tumor Diagnosis and Therapeutics Market: Type Estimates & Trend Analysis
                     4.1. Type Movement Analysis & Market Share, 2015 & 2025
                     4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following type:
                           4.2.1. MRI
                           4.2.2. CT scan
                           4.2.3. Tissue sampling
                           4.2.4. PET-CT scan
                           4.2.5. Cerebral arteriogram
                           4.2.6. Lumbar puncture
                           4.2.7. Molecular testing
                           4.2.8. EEG
Chapter 5. Brain Tumor Diagnosis and Therapeutics Market: Therapeutics Estimates & Trend Analysis
                     5.1. Therapeutics Movement Analysis & Market Share, 2015 & 2025
                     5.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following therapeutics:
                           5.2.1. Surgery
                           5.2.2. Radiation therapy
                           5.2.3. Chemotherapy
                           5.2.4. Immunotherapy
                           5.2.5. Targeted therapy
Chapter 6. Brain Tumor Diagnosis and Therapeutics Market: Regional Estimates & Trend Analysis
                     6.1. Brain Tumor Diagnosis and Therapeutics Regional Market Share, 2015 & 2025
                     6.2. North America
                           6.2.1. U.S.
                                6.2.1.1. U.S. revenue estimates and forecasts, by type, 2014 - 2025 (USD Million)
                                6.2.1.2. U.S. Revenue estimates and forecasts, by therapeutics, 2014 - 2025 (USD Million)
                           6.2.2. Canada
                                6.2.2.1. Canada revenue estimates and forecasts, by type, 2014 - 2025 (USD Million)
                                6.2.2.2. Canada revenue estimates and forecasts, by therapeutics, 2014 - 2025 (USD Million)
                     6.3. Europe
                           6.3.1. U.K.
                                6.3.1.1. U.K. revenue estimates and forecasts, by type, 2014 - 2025 (USD Million)
                                6.3.1.2. U.K. revenue estimates and forecasts, by therapeutics, 2014 - 2025 (USD Million)
                           6.3.2. Germany
                                6.3.2.1. Germany revenue estimates and forecasts, by type, 2014 - 2025 (USD Million)
                                6.3.2.2. Germany revenue estimates and forecasts, by therapeutics, 2014 - 2025 (USD Million)
                     6.4. Asia Pacific
                           6.4.1. Japan
                                6.4.1.1. Japan revenue estimates and forecasts, by type, 2014 - 2025 (USD Million)
                                6.4.1.2. Japan revenue estimates and forecasts, by therapeutics, 2014 - 2025 (USD Million)
                           6.4.2. India
                                6.4.2.1. India revenue estimates and forecasts, by type, 2014 - 2025 (USD Million)
                                6.4.2.2. India revenue estimates and forecasts, by therapeutics, 2014 - 2025 (USD Million)
                     6.5. Latin America
                           6.5.1. Brazil
                                6.5.1.1. Brazil revenue estimates and forecasts, by type, 2014 - 2025 (USD Million)
                                6.5.1.2. Brazil revenue estimates and forecasts, by therapeutics, 2014 - 2025 (USD Million)
                           6.5.2. Mexico
                                6.5.2.1. Mexico revenue estimates and forecasts, by type, 2014 - 2025 (USD Million)
                                6.5.2.2. Mexico revenue estimates and forecasts, by therapeutics, 2014 - 2025 (USD Million)
                     6.6. MEA
                           6.6.1. South Africa
                                6.6.1.1. South Africa revenue estimates and forecasts, by type, 2014 - 2025 (USD Million)
                                6.6.1.2. South Africa revenue estimates and forecasts, by therapeutics, 2014 - 2025 (USD Million)
Chapter 7. Competitive Landscape
                     7.1. Strategy Framework
                     7.2. Company Profiles
                           7.2.1. GE Healthcare
                                7.2.1.1. Company overview
                                7.2.1.2. Geographic foothold
                                7.2.1.3. Financial performance
                                7.2.1.4. Product benchmarking
                                7.2.1.5. Strategic initiatives
                           7.2.2. Hitachi, Ltd.
                                7.2.2.1. Company overview
                                7.2.2.2. Geographic foothold
                                7.2.2.3. Financial performance
                                7.2.2.4. Product benchmarking
                                7.2.2.5. Strategic initiatives
                           7.2.3. Philips Healthcare
                                7.2.3.1. Company overview
                                7.2.3.2. Geographic foothold
                                7.2.3.3. Financial performance
                                7.2.3.4. Product benchmarking
                                7.2.3.5. Strategic initiatives
                           7.2.4. Siemens Healthineers
                                7.2.4.1. Company overview
                                7.2.4.2. Geographic foothold
                                7.2.4.3. Financial performance
                                7.2.4.4. Product benchmarking
                                7.2.4.5. Strategic initiatives
                           7.2.5. Toshiba Corporation
                                7.2.5.1. Company overview
                                7.2.5.2. Geographic foothold
                                7.2.5.3. Financial performance
                                7.2.5.4. Product benchmarking
                                7.2.5.5. Strategic initiatives
                           7.2.6. Fujifilm Corporation
                                7.2.6.1. Company overview
                                7.2.6.2. Geographic foothold
                                7.2.6.3. Financial performance
                                7.2.6.4. Product benchmarking
                                7.2.6.5. Strategic initiatives
                           7.2.7. Shimadzu Corporation
                                7.2.7.1. Company overview
                                7.2.7.2. Geographic foothold
                                7.2.7.3. Financial performance
                                7.2.7.4. Product benchmarking
                                7.2.7.5. Strategic initiatives
                           7.2.8. Carestream Health
                                7.2.8.1. Company overview
                                7.2.8.2. Geographic foothold
                                7.2.8.3. Financial performance
                                7.2.8.4. Product benchmarking
                                7.2.8.5. Strategic initiatives


List of Tables

1. North America brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
2. North America brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
3. U.S. brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
4. U.S. brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
5. Canada brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
6. Canada brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
7. Europe brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
8. Europe brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
9. U.K. brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
10. U.K. brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
11. Germany brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
12. Germany brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
13. Asia Pacific brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
14. Asia Pacific brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
15. Japan brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
16. Japan brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
17. India brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
18. India brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
19. Latin America brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
20. Latin America brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
21. Brazil brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
22. Brazil brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
23. Mexico brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
24. Mexico brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
25. MEA brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
26. MEA brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)
27. South Africa brain tumor diagnosis and therapeutics market, by type, 2014 - 2025 (USD Million)
28. South Africa brain tumor diagnosis and therapeutics market, by therapeutics, 2014 - 2025 (USD Million)


List of Figures

1. Market summary
2. Market trends & outlook
3. Market segmentation & scope
4. Market driver relevance analysis (Current & future impact)
5. Market restraint relevance analysis (Current & future Impact)
6. Penetration & growth prospect mapping
7. Brain tumor diagnosis and therapeutics market PEST by SWOT analysis
8. Porter’s five forces analysis
9. Brain tumor diagnosis and therapeutics market type outlook: Key takeaways
10. Brain tumor diagnosis and therapeutics market: Type movement analysis
11. MRI market 2014 - 2025 (USD Million)
12. CT scan market 2014 - 2025 (USD Million)
13. Tissue sampling market 2014 - 2025 (USD Million)
14. PET-CT scan market 2014 - 2025 (USD Million)
15. Cerebral arteriogram market 2014 - 2025 (USD Million)
16. Lumbar puncture market 2014 - 2025 (USD Million)
17. Molecular testing market 2014 - 2025 (USD Million)
18. EEG market 2014 - 2025 (USD Million)
19. Brain tumor diagnosis and therapeutics market therapeutics outlook key takeaways
20. Brain tumor diagnosis and therapeutics market: therapeutics movement analysis
21. Surgery market 2014 - 2025 (USD Million)
22. Radiation therapy market 2014 - 2025 (USD Million)
23. Chemotherapy market 2014 - 2025 (USD Million)
24. Immunotherapy market 2014 - 2025 (USD Million)
25. Targeted therapy market 2014 - 2025 (USD Million)
26. Regional market place: Key takeaways
27. Regional outlook, 2015 & 2025
28. North America brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
29. U.S. brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
30. Canada brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
31. Europe brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
32. U.K. brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
33. Germany brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
34. Asia Pacific brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
35. Japan brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
36. India brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
37. Latin America brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
38. Brazil brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
39. Mexico brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
40. MEA brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)
41. South Africa brain tumor diagnosis and therapeutics market, 2014 - 2025 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.